Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-014939
Filing Date
2025-05-29
Accepted
2025-05-29 21:39:50
Documents
1
Period of Report
2025-05-29

Document Format Files

Seq Description Document Type Size
1 form4-05302025_010547.html 4  
1 form4-05302025_010547.xml 4 4183
  Complete submission text file 0001415889-25-014939.txt   5762
Mailing Address C/O NEW LEAF VENTURE PARTNERS TIMES SQ TOWER, 7 TIMES SQ, STE 3502 NEW YORK NY 10036
Business Address
Becker Daniel J. (Reporting) CIK: 0001752139 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40598 | Film No.: 251006051

Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Issuer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)